First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like Psilocybin therapy reduces depression in clinicians after pandemic frontline work December 5, 2024 Exploring long COVID: Insights into prevalence, pathophysiology, and treatment August 4, 2024 Keto Cheesecake Fluff (Sugar-Free Recipe) January 26, 2024